Effects of platelet rich plasma on frozen embryo transfer process
Phase 2
- Conditions
- oninflammatory disorders of female genital tract.Complication associated with artificial fertilization, unspecified
- Registration Number
- IRCT2016072229027N1
- Lead Sponsor
- Vice Chancellor for research of Shahid Beheshti University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 30
Inclusion Criteria
Body mass index (BMI) below 30; unadequate endometrium (endometrial thickness below 7 mm); history of hematologic disease3 failed embryo transfer
Exclusion criteria: history of hematologic disorders; uterine abnormality (acquired or congenital); unwillingness to continue
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Clinical pregnancy. Timepoint: 4 weeks after embryo transfer. Method of measurement: Transvaginal ultrasound.;Chemical pregnancy. Timepoint: 2 weeks after embryo transfer. Method of measurement: Serum BHCG.;Endometrial thickness. Timepoint: 48 hours after PRP. Method of measurement: The most ndometrial thickening in transvaginal ultrasound.
- Secondary Outcome Measures
Name Time Method Ongoing pregnancy. Timepoint: 10 weeks after embryo transfer. Method of measurement: Fetal heart beat in ultrasound.;Abortion. Timepoint: Before 20 weeks of pregnancy. Method of measurement: Fetal demise before 20 weeks of gestation.